Lansoprazole Patent Expiration

Lansoprazole was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Prevacid on May 10, 1995. Other drugs containing Lansoprazole are Lansoprazole, Prevacid 24 Hr, Prevacid Iv. 31 different companies have introduced drugs containing Lansoprazole.


Lansoprazole Patents

Given below is the list of patents protecting Lansoprazole, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lansoprazole US11077055 Orally disintegrating compositions Apr 21, 2036 Dexcel
Lansoprazole US11986554 Orally disintegrating compositions Apr 21, 2036 Dexcel
Prevacid Iv US7396841

(Pediatric)

Injections Feb 17, 2022

(Expired)

Takeda Pharms Na
Prevacid Iv US7396841 Injections Aug 17, 2021

(Expired)

Takeda Pharms Na
Prevacid US6328994

(Pediatric)

Orally disintegrable tablets Nov 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US7431942

(Pediatric)

Orally disintegrable tablets Nov 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US7875292

(Pediatric)

Orally disintegrable tablets Nov 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US9901546

(Pediatric)

Orally disintegrable tablets Nov 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US6328994 Orally disintegrable tablets May 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US7431942 Orally disintegrable tablets May 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US7875292 Orally disintegrable tablets May 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US9901546 Orally disintegrable tablets May 17, 2019

(Expired)

Takeda Pharms Usa
Prevacid US7399485

(Pediatric)

Rapidly Disintegrable solid preparation Nov 26, 2018

(Expired)

Takeda Pharms Usa
Prevacid US7399485 Rapidly Disintegrable solid preparation May 26, 2018

(Expired)

Takeda Pharms Usa
Prevacid US5464632

(Pediatric)

Rapidly disintegratable multiparticular tablet May 07, 2013

(Expired)

Takeda Pharms Usa
Prevacid US5464632 Rapidly disintegratable multiparticular tablet Nov 07, 2012

(Expired)

Takeda Pharms Usa



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lansoprazole's patents.

Given below is the list recent legal activities going on the following patents of Lansoprazole.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 03 Aug, 2021 US11077055
Recordation of Patent Grant Mailed 03 Aug, 2021 US11077055
Email Notification 15 Jul, 2021 US11077055
Issue Notification Mailed 14 Jul, 2021 US11077055
Dispatch to FDC 28 Jun, 2021 US11077055
Application Is Considered Ready for Issue 28 Jun, 2021 US11077055
Issue Fee Payment Verified 23 Jun, 2021 US11077055
Issue Fee Payment Received 23 Jun, 2021 US11077055
Electronic Review 19 Jun, 2021 US11077055
Email Notification 18 Jun, 2021 US11077055


Lansoprazole's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lansoprazole Generic API Manufacturers

Several generic applications have been filed for Lansoprazole. The first generic version for Lansoprazole was by Teva Pharmaceuticals Usa and was approved on Nov 10, 2009. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 4, 2024.

Given below is the list of companies who have filed for Lansoprazole generic, along with the locations of their manufacturing plants worldwide.